Advertisement

Topics

Pharmaceutical Care for Diabetes Type 2 Patients: a Randomised Controlled Trial

2014-08-27 03:46:43 | BioPortfolio

Summary

The objective of this study is to evaluate the therapeutic effectiveness and cost-effectivity of pharmaceutical care for diabetes type 2 patients. Patients will be randomly allocated to the control group ( = no input from pharmacist) or intervention group ( = with pharmaceutical care at baseline and follow-up visits over 6 months).

Study Design

Allocation: Randomized, Control: Placebo Control, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Conditions

Diabetes Mellitus

Intervention

Pharmaceutical care at baseline and follow-up visits over 6 months

Location

University Hospital Ghent
Ghent
Belgium
9000

Status

Completed

Source

University Ghent

Results (where available)

View Results

Links

Published on BioPortfolio: 2014-08-27T03:46:43-0400

Clinical Trials [3424 Associated Clinical Trials listed on BioPortfolio]

Pharmaceutical Care Service in Diabetes

The purpose of this study is to examine the effectiveness of pharmaceutical care service in the management of poorly controlled type 2 diabetes mellitus.

Understanding and Improving Diabetes Care for Ethnic Minorities

In this study, we are testing the effectiveness of an intervention known as "Coached Care" to improve health outcomes and quality of care of patients being treated for type 2 diabetes, par...

Effectiveness of Pharmacotherapy Follow-up Care in Outpatients With Type 2 Diabetes Mellitus

Hypothesis: Pharmacotherapy follow-up can improve clinical outcomes of outpatients with type 2 diabetes mellitus. Methods: In this single blind, placebo-controlled trial, the participants...

The vBlocT2D Study

Overall aim: To demonstrate that weight loss through vBloc Therapy in combination with usual care will achieve better glycemic control for patients with obesity and type 2 diabetes than us...

Pharmacotherapy Follow-up in Older HIV-infected Patients

Cardiovascular diseases (CVD) are the main cause of death in Spain. In HIV patients, the uncontrolled viral replication, antiretroviral therapy (ART) and coinfections contribute to develop...

PubMed Articles [23124 Associated PubMed Articles listed on BioPortfolio]

Text Messaging to Improve Disease Management in Patients With Painful Diabetic Peripheral Neuropathy.

Purpose The purpose of the study was to determine the impact of educational text messages on diabetes self-management activities and outcomes in patients with painful diabetic peripheral neuropathy (p...

Effects of physician's specialty on regular chronic kidney disease care in predialysis: A population-based cross-sectional study.

Late referral in chronic kidney disease (CKD) is associated with irregular care and poor prognosis. How the specialty of healthcare provider affect late referral and irregular CKD care remain unclear....

The association between outpatient follow-up visits and all-cause non-elective 30-day readmissions: A retrospective observational cohort study.

As an effort to reduce hospital readmissions, early follow-up visits were recommended by the Society of Hospital Medicine. However, published literature on the effect of follow-up visits is limited wi...

Web Support for Weight-Loss Interventions: PREDIRCAM2 Clinical Trial Baseline Characteristics and Preliminary Results.

An ongoing clinical trial is testing the efficacy of web telematic support in a structured program for obesity treatment and diabetes prevention. Participants were recruited from two tertiary-care hos...

High loss to follow-up of children on antiretroviral treatment in a primary care HIV clinic in Johannesburg, South Africa.

Outcomes of HIV-infected children have improved dramatically over the past decade, but are undermined by patient loss to follow-up (LTFU). We assessed patterns of LTFU among HIV-infected children rece...

Medical and Biotech [MESH] Definitions

Visits made by patients to health service providers' offices for diagnosis, treatment, and follow-up.

Study subjects in COHORT STUDIES whose outcomes are unknown e.g., because they could not or did not wish to attend follow-up visits.(from Dictionary of Epidemiology, 5th ed.)

Economic aspects of the fields of pharmacy and pharmacology as they apply to the development and study of medical economics in rational drug therapy and the impact of pharmaceuticals on the cost of medical care. Pharmaceutical economics also includes the economic considerations of the pharmaceutical care delivery system and in drug prescribing, particularly of cost-benefit values. (From J Res Pharm Econ 1989;1(1); PharmacoEcon 1992;1(1))

Specialized healthcare delivered as a follow-up or referral from a PRIMARY CARE provider.

A traditional term for all the activities which a physician or other health care professional normally performs to insure the coordination of the medical services required by a patient. It also, when used in connection with managed care, covers all the activities of evaluating the patient, planning treatment, referral, and follow-up so that care is continuous and comprehensive and payment for the care is obtained. (From Slee & Slee, Health Care Terms, 2nd ed)

More From BioPortfolio on "Pharmaceutical Care for Diabetes Type 2 Patients: a Randomised Controlled Trial"

Advertisement
Quick Search
Advertisement
Advertisement

 

Searches Linking to this Trial